We observed a similar increase in weight gain in both the DR3 agonist-treated and isotype control-treated cohorts that were placed on the HFD and both developed diet-induced obesity when compared to the NCD fed mice (Fig. 2b). This evidence concerns the gene TNFRSF25 and obesity disorder.